Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masport Botulinum toxin injection to reduce recurrence of bulbar urethral stricture
IRCT20191222045852N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of neuronox in bulbar urethral stricture (BUS), sponsored by Shahid Beheshti University of Medical Sciences. Started Apr 2019; status: completed.
02
Drugs
neuronox
03
Conditions
bulbar urethral stricture (BUS)
Beyond the preview
Go deeper on IRCT20191222045852N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191222045852N1.